News
The goals of a Phase 2 clinical trial are to determine if the treatment is effective and to gather more safety data. Researchers use the data from Phase 2 trials to refine their research questions ...
8h
The Kenya Times on MSN20,000 Kenyans Among Participants of Ksh72.5 Billion Vaccine TrialA new tuberculosis (TB) vaccine candidate, M72/AS01E, has entered Phase III clinical trials, with Kenyans among the 20,000 ...
Phase 1 Trials There is little ethical discourse and few publications of phase 1 trials involving healthy volunteers. [17, 18] Phase 1 clinical trials are the gatekeepers for all clinical research.
6d
IFLScience on MSN"Groundbreaking" Obesity Treatment That Turns Up The Heat On Fat Cells Passes Phase I Clinical TrialsIn what is being hailed as a “groundbreaking achievement” for Uruguay and South America, a weight loss drug has successfully ...
Key Facts Clinical trials move through four structured phases, from safety testing to long-term effects. Adaptive, basket, and umbrella trials are making cancer research faster and more flexible.
Pioneering approach to halting the chronic neuroinflammation responsible for neurodegeneration- Trial to assess safety, PK and detect early signs of efficacy- Initial data expected in mid-2026 ...
The successful completion of phases one through five of Nexalin’s virtual clinic infrastructure positions the Company to further expand research collaborations, advance regulatory approvals, and ...
LOS ANGELES-- (BUSINESS WIRE)-- Pelage Pharmaceuticals, a clinical-stage regenerative medicine company, today announced positive results from its Phase 2a clinical trial of PP405 — a topical ...
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy: Paris, France Wednesday, July 30, ...
4d
News Medical on MSNMassey becomes first U.S. site to enroll patients in global Phase 2a trial of first-in-class therapy for T-cell lymphomaVCU Massey Comprehensive Cancer Center is the first site in the United States to be activated in a global Phase 2a clinical ...
The Company plans to extend its Phase II trial of HT-001 in Cancer Patients with skin toxicities in European Union (EU) Countries NEW YORK, July 29, 2025 /PRNewswire/ ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results